AgomAb Therapeutics N.V. American Shares
AGMB | NASDAQ
$7.49
-$0.46 (-5.79%)
At close: Oct 30, 2026, 4:00 PM ET
$7.49
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|
Net Income | -17.4M | -18.28M | -11.73M |
Depreciation & Amortization | -83K | 107K | 85K |
Stock-Based Compensation | 1.42M | 1.34M | 499K |
Other Working Capital | 1.37M | 127K | -1.62M |
Other Non-Cash Items | 1.52M | 3.07M | 333K |
Deferred Income Tax | n/a | n/a | n/a |
Change in Working Capital | 1.37M | 127K | -1.62M |
Operating Cash Flow | -13.17M | -13.64M | -12.44M |
Capital Expenditures | -4K | n/a | -363K |
Cash Acquisitions | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a |
Other Investing Acitivies | -30M | n/a | n/a |
Investing Cash Flow | -30M | n/a | -363K |
Debt Repayment | -34K | -156K | -63K |
Common Stock Repurchased | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -130K |
Financial Cash Flow | -34K | -156K | 81.86M |
Net Cash Flow | -43.17M | -13.79M | 68.86M |
Free Cash Flow | -13.18M | -13.64M | -12.8M |
Adj. Free Cash Flow | -14.6M | -14.98M | -13.3M |
Maintenance CapEx | -4K | n/a | -85K |
Growth CapEx | n/a | n/a | -278K |
Owner Earnings | -13.18M | -13.64M | -12.52M |
Add to Watchlist
Select watchlists to add or remove AGMB